Skip to main content
. 2021 Apr 6;11(4):320. doi: 10.3390/life11040320

Figure 1.

Figure 1

Flow-diagram of the study design used to screen, identify, and validate new lncRNA as prostate cancer (PCa) specific biomarkers.